313 related articles for article (PubMed ID: 17640982)
1. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
[TBL] [Abstract][Full Text] [Related]
2. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
Rickard AJ; Funder JW; Fuller PJ; Young MJ
Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342
[TBL] [Abstract][Full Text] [Related]
3. Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats.
Young M; Funder JW
Endocrinology; 2004 Jul; 145(7):3153-7. PubMed ID: 15059952
[TBL] [Abstract][Full Text] [Related]
4. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Young MJ; Moussa L; Dilley R; Funder JW
Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats.
Lam EY; Funder JW; Nikolic-Paterson DJ; Fuller PJ; Young MJ
Endocrinology; 2006 Jul; 147(7):3623-9. PubMed ID: 16627578
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoids, hypertension, and cardiac fibrosis.
Young M; Fullerton M; Dilley R; Funder J
J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995
[TBL] [Abstract][Full Text] [Related]
7. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.
Wilson P; Morgan J; Funder JW; Fuller PJ; Young MJ
Clin Sci (Lond); 2009 May; 116(9):731-9. PubMed ID: 18990085
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid and mineralocorticoid receptors regulate paracellular permeability in a primary cultured gill epithelium.
Kelly SP; Chasiotis H
J Exp Biol; 2011 Jul; 214(Pt 14):2308-18. PubMed ID: 21697422
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K
Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271
[TBL] [Abstract][Full Text] [Related]
11. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
Young M; Head G; Funder J
Am J Physiol; 1995 Oct; 269(4 Pt 1):E657-62. PubMed ID: 7485478
[TBL] [Abstract][Full Text] [Related]
12. Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments.
Jadavji NM; Supina RD; Metz GA
Neuroendocrinology; 2011; 94(4):278-90. PubMed ID: 22024815
[TBL] [Abstract][Full Text] [Related]
13. Na/H exchange isoform 1 is involved in mineralocorticoid/salt-induced cardiac injury.
Fujisawa G; Okada K; Muto S; Fujita N; Itabashi N; Kusano E; Ishibashi S
Hypertension; 2003 Mar; 41(3):493-8. PubMed ID: 12623949
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
Navarro-Zaragoza J; Laorden ML; Milanés MV
Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
[TBL] [Abstract][Full Text] [Related]
15. Activation of mineralocorticoid receptors by exogenous glucocorticoids and the development of cardiovascular inflammatory responses in adrenalectomized rats.
Young MJ; Morgan J; Brolin K; Fuller PJ; Funder JW
Endocrinology; 2010 Jun; 151(6):2622-8. PubMed ID: 20410198
[TBL] [Abstract][Full Text] [Related]
16. Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.
Fujisawa G; Dilley R; Fullerton MJ; Funder JW
Endocrinology; 2001 Aug; 142(8):3625-31. PubMed ID: 11459811
[TBL] [Abstract][Full Text] [Related]
17. Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.
Hirata A; Maeda N; Nakatsuji H; Hiuge-Shimizu A; Okada T; Funahashi T; Shimomura I
Biochem Biophys Res Commun; 2012 Mar; 419(2):182-7. PubMed ID: 22326264
[TBL] [Abstract][Full Text] [Related]
18. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
[TBL] [Abstract][Full Text] [Related]
19. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
McCormick SD; Regish A; O'Dea MF; Shrimpton JM
Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
